Lupus Clinical Trial
Official title:
Disease Progression and Activity in the Carolinas Lupus Study - MUSC Medical University of South Carolina Follow up
Verified date | October 26, 2006 |
Source | National Institutes of Health Clinical Center (CC) |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study is a continuing follow-up of patients with systemic lupus erythematosus (SLE) and
control subjects enrolled in the Carolina Lupus Study and the University of North Carolina
(UNC) Lupus Nephritis Study. SLE is a severe, chronic, disabling autoimmune disease that
significantly affects health and quality of life. The disease most often affects young to
middle-aged adults, and therefore can also affect work and disability. There is currently
little information on work-related disability related to SLE. The goals of the current study
are to:
- Determine health and work status of patients and controls in the Carolina Lupus Study
and the UNC Lupus Nephritis Study;
- Develop and test methods for obtaining disease data from university- and community-based
physicians in the study area;
- Examine the associations between sociodemographic, work-related factors, disease damage,
and work disability among SLE patients and controls; and
- Assess the role of demographic and socioeconomic factors, psychosocial attributes, and
potentially modifiable behavior or environmental factors (e.g., smoking, occupational
exposures, medication compliance) in disease damage measures, and in the increased
severity of disease among African-American patients.
Patients and control subjects enrolled in the Carolina Lupus Study and the University of
North Carolina Lupus Nephritis Study are eligible for this protocol.
Subjects will participate in a 30-minute telephone interview that includes questions related
to their current health status, medical care utilization, work and disability issues,
psychosocial attributes (e.g., helplessness, social support), and changes in environmental
exposures since the previous follow-up interview in 2001. With the patients' permission,
disease damaged will be assessed using a standardized form to be completed by the patients'
physician or using information obtained from the patient's medical record.
Status | Completed |
Enrollment | 716 |
Est. completion date | October 26, 2006 |
Est. primary completion date | |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
- ELIGIBILITY CRITERIA: Participants to be contacted for this follow-up study are enrolled as part of the Disease Progression and Activity in the Carolina Lupus Study (Protocol Number OH97-E-N002) and the UNC Nephritis Study (Lupus Nephritis: Role of Environmental and Occupational Exposures, Protocol Number 01-E-N154). There will be no new subject enrollment. Participants were initially recruited from collaborating hospitals and physicians in North and South Carolina. Recruitment ended in July, 1999. Lupus most often affects young women and this is shown by the makeup of study participants. The demographics of the study participants is described in Table 2. Most CLU participants were born in North or South Carolina. More than half of CLU patients are African Americans. There is no involvement of special classes of subjects. |
Country | Name | City | State |
---|---|---|---|
United States | National Institute of Environmental Health Sciences (NIEHS) | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Institute of Environmental Health Sciences (NIEHS) |
United States,
Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum. 1999 Feb;42(2):338-46. — View Citation
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06013995 -
A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus
|
Phase 1 | |
Recruiting |
NCT03952624 -
Patient-Centered Assessment of Symptoms and Outcomes
|
||
Terminated |
NCT01389895 -
Safety Study of AMG 557 in Subjects With Subacute Cutaneous Lupus Erythematosus
|
Phase 1 | |
Completed |
NCT00710021 -
Vitamin D3 in Systemic Lupus Erythematosus
|
Phase 2 | |
Completed |
NCT02265744 -
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
|
Phase 2 | |
Recruiting |
NCT06445127 -
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging)
|
N/A | |
Completed |
NCT00581763 -
Long-Term Outcome of Children and Adolescents With Anti-Phospholipid Antibodies
|
N/A | |
Recruiting |
NCT01172002 -
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
|
N/A | |
Completed |
NCT00299819 -
Safety and Tolerability of MEDI-545 in Patients Who Have Systemic Lupus Erythematosus (SLE)
|
Phase 1 | |
Completed |
NCT00054938 -
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
|
Phase 2 | |
Terminated |
NCT03953690 -
Acceptability and Persistence of the Use of a Patient-centred E-health Tool for Lupus Patients Followed in a Specialised Centre in France
|
||
Recruiting |
NCT05715463 -
Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity
|
N/A | |
Enrolling by invitation |
NCT05321108 -
Aerobic Exercise Versus Whole-Body Vibration on Fatigue, Functional Capacity, Quality of Life in Systemic Lupus
|
N/A | |
Completed |
NCT00482989 -
A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
|
Phase 1 | |
Completed |
NCT00657189 -
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
|
Phase 2 | |
Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
Completed |
NCT03402087 -
A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
|
Phase 1 | |
Completed |
NCT02857452 -
Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
|
N/A | |
Terminated |
NCT03186794 -
Aerobic Exercise in Women With Systemic Lupus Erythematosus
|
N/A | |
Recruiting |
NCT05922722 -
Clarifying Misbeliefs About Hydroxychloroquine: Developing a Decision Aid for Patients With Lupus
|